SCHEMBL4200801

SCHEMBL4200801

Cc1noc(-c2ccccc2)c1NC(=O)NC1CCCCC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.58
MAPT P10636 3/20 0.58
EPHX1 P07099 4/20 0.55
ALDH1A1 P00352 4/20 0.53
HTT P42858 2/20 0.53
HSD17B10 Q99714 2/20 0.53
RAB9A P51151 4/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
EPHX2 P34913 1/20 0.52
LPAR1 Q92633 1/20 0.51
LPAR3 Q9UBY5 1/20 0.51
KMT2A Q03164 2/20 0.50
MEN1 O00255 1/20 0.50
LMNA P02545 2/20 0.49
S1PR1 P21453 1/20 0.49
NPC1 O15118 3/20 0.47
GAA P10253 1/20 0.46
HPGD P15428 1/20 0.46
GFER P55789 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1911307 0.83 MAPT (0.53) KDM4EMAPTALDH1A1SMN1; SMN2LPAR1
SCHEMBL4105147 0.79 MAPT (0.56) KDM4EMAPTEPHX2LPAR1LPAR3
SCHEMBL5537590 0.79 ATM (0.56) KDM4EMAPTALDH1A1HTTRAB9A
SCHEMBL4035675 0.79 MAPT (0.67) KDM4EMAPTALDH1A1HTTSMN1; SMN2
SCHEMBL6867288 0.78 MAPK8 (0.48) KDM4EMAPTEPHX1LPAR1LPAR3
SCHEMBL6867297 0.78 MAPK8 (0.48) KDM4EMAPTEPHX1LPAR1LPAR3
SCHEMBL6456303 0.78 KDM4E (0.43) KDM4EMAPTLPAR1LPAR3
SCHEMBL6456296 0.78 KDM4E (0.43) KDM4EMAPTLPAR1LPAR3
SCHEMBL4030374 0.78 MCHR1 (0.56) KDM4EMAPTEPHX1ALDH1A1HSD17B10
SCHEMBL4030372 0.78 MCHR1 (0.56) KDM4EMAPTEPHX1ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1611109-A4 NOVEL QUINAZOLINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF TAISHO PHARMACEUTICAL CO LTD (JP) 2009-06-24 EP claimed
JP-2006522109-A 2006-09-28 JP claimed
EP-1611109-A1 NOVEL QUINAZOLINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF TAISHO PHARMACEUTICAL CO., LTD (JP) 2006-01-04 EP claimed
WO-2004087680-A1 NOVEL QUINAZOLINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF TAISHO PHARMACEUTICAL CO., LTD. (JP) 2004-10-14 WO claimed